Virtual Tumor Board PDL1 Negative NSCLC With Reyes Bernabé And Hoss Borghaei

Virtual Tumor Board PDL1 Negative NSCLC With Reyes Bernabé And Hoss Borghaei

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of metastatic, PDL1 negative NSCLC. He is joined by Dr. Hossein Borghaei and Dr. Reyes Bernabe Caro. Dr. Borghaei is a professor and Chief of Thoracic Oncology at Fox Chase Cancer Center in Philadelphia. He was the lead author for CheckMate 057, was involved in many of the landmark immunotherapy trials, and is the national PI for the ongoing INSIGNA trial. Dr. Reyes Bernabe Caro is the Section Chief of Medical Oncology and Head of the Thoracic Tumor Unite at the Hospital Universitario Virgen Rocio in Seville, Spain. She also has extensive experience in immunotherapy combinations and is an author on the NADIM and CheckMate 227 studies.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(392)

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped ...

23 Jun 45min

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights -...

12 Jun 39min

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

In Part 2 of the ASCO 2026 Highlights series, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Julie Brahmer and Dr. Solange Peters to discuss some of the most notable immunotherapy adva...

9 Jun 40min

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

In this Part 1 of 2 ASCO 2026 Highlights episodes, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Alice Shaw and Dr. Jonathan Goldman to review some of the most impactful targeted ther...

5 Jun 45min

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Natalie Brown and Dr. Aurora Lucas to explore how patients and caregivers are using artificial intelligence in the conte...

19 Mai 46min

LCC in Italian: Resectable EGFR-mutant NSCLC

LCC in Italian: Resectable EGFR-mutant NSCLC

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuse...

8 Mai 49min

AACR 2026 Highlights: KRAS Updates

AACR 2026 Highlights: KRAS Updates

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 Annual Meeting with Dr. Deborah Doroshow, Dr. David...

5 Mai 46min

LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

This episode of Lung Cancer Considered, part of IASLC’s World Language Series, features host Dr. Narjust Florez leading a Spanish-language discussion with Dr. José Corona-Cruz and Dr. Diego Carrillo o...

24 Apr 48min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
liberal-halvtime
rekommandert
sinnsyn
villmarksliv
dekodet-2
tomprat-med-gunnar-tjomlid
smart-forklart
rss-nysgjerrige-norge
fjellsportpodden
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
nevropodden
rss-rekommandert
rss-paradigmepodden
rss-overskuddsliv
abels-tarn
rss-bondevennen